Global Brain Implants Market- Industry Analysis and Forecast (2019-2027) – By Product, Application, and Region.

Global Brain Implants Market was valued at US$ 370 Mn in 2019 and is expected to reach US$ 750 Mn by 2027, at a CAGR of 9.23 % during a forecast period. Global Brain Implants Market The report study has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Global Brain Implants Market Definition

Brain implants are neural implants. Neural interfaces offer a new way of treating conditions like dementia, paralysis, mental health conditions, or obesity. Brain implant devices are used for the treatment of patients with neurological disorders like Parkinson's disease, epilepsy, and chronic pain. Global Brain Implants Market Snapshot

Global Brain Implants Market Dynamics:

Brain implants are technical devices that are generally placed on the surface of the brain. The brain implants are assessing in the treatment of the damaged parts of the brain. The implants help in the proper functioning of the brain like memory, senses, and physical movements. Incidences of neurological disorders like Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors are expected to increase the demand for brain implants. The geriatric population is stimulating market growth. An introduction of innovative and cost-efficient technology for brain implant treatment is expected to drive the market growth during the forecast period. In addition, researchers are focusing to develop a method to stimulate brain tissues electrically without opening the skull. On the other hand, individuals with a brain implant require to undergo several additional surgeries to replace them and the high cost of repeated surgery are some of the prominent factors that is expected to limit the market growth.

Global Brain Implants Market Dynamics

In the brain implant market, several key companies and labs are developing neural interface software. For instance, Elon Musk, CEO of the Testla automotive company, is planning human trials year to insert electrodes into the brains of people with locked-in syndrome to help them communicate. With the massive strides in the automotive transportation sector by Tesla and the progress of SpaceX, Elon Musk has repeatedly established remarkable ambition to shape the future of humidity. The US Billionaire has unveiled plans to implant computer chips in people’s brains. It is expected to treat brain diseases and enable superhuman intelligence. Furthermore, Facebook-founder Mark Zuckerberg has also expressed his interest in telepathic typing. The social media companies are focusing on the creation to transcribe words at a rate of 100-words per minute by thinking. An increase in the number of research activities to lead the technological breakthroughs like self-charging implants and memory chips are expected to provide growth opportunities for key players during the forecast period.

Global Brain Implants Market Segment Analysis:

An innovative brain implant device can record activity in thousands of neurons. The researchers are spending years designing and redesign the device and the process for making it. The Deep-brain stimulation (DBS) is already used to suppress the shakes and tremors of people with Parkinson’s disease. In that, electrodes are implanted into a specific part of the brain through wires under the skin to a pacemaker-like stimulator in the chest. It sends out electrical signals that stifle the parts of the brain. Also, the researchers are beginning to test similar devices, or new types of implants, which is expected to help people with other complex neurological conditions. Parkinson's disease held the XX% share in the global brain implant market in 2019. It is one of the most common neurodegenerative disorders. The rise in a number of FDA approvals in the U.S. for deep brain stimulation therapies is expected to help the Parkinson's disease treatment. In addition, the long-term costs of medications and treatment for Parkinson’s disease are expected to increase the adoption of brain implants.

Global Brain Implants Market Regional Analysis:

North America region held the XX% share in 2019 and is projected to hold the dominant position in the global brain implant market during the forecast period. The dominant position in the market is attributed to the high standards of quality maintained by the medical device key players. The growth in the aging population, the burden of Parkinson’s disease, and demand for advanced devices are some of the prominent factors behind the regional market growth. According to the Parkinson's disease Foundation, indications of Parkinson's disease have witnessed usually at an average age of 60. In Canada, more than 100,000 people suffer Parkinson's disease in 2019 that is expected to increase the demand for brain implants. Canada’s healthcare system has implemented a publicly-funded insurance program, which helps to bring together doctors and hospitals to control the cost of treatment.

Global Brain Implants Market Competitive Analysis:

Some of the medical technology firms are focusing to develop implants that can be inserted into brain tissue and attach themselves to neurons. Also, researchers are working to develop minimally invasive methods to hack the human brain and pinch out more of its potential. The prominent key players like Boston Scientific, Medtronic, St. Jude Medical, Nevro Corporation, and NDI Medical LLC are contributing the majority of the market revenue. They are involved in adopting extensive growth strategies like differentiation and diversification of product portfolios, and broadening marketing and distribution channels to increase the outreach of their products. The objective of the report is to present a comprehensive analysis of the Global Brain Implants Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Brain Implants Market dynamics, structure by analyzing the market segments and projects the Global Brain Implants Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Brain Implants Market make the report investor’s guide.

Scope of the Global Brain Implants Market

Global Brain Implants Market, by Product

• Deep brain stimulation • Spinal cord stimulation • Vagus nerve stimulation

Global Brain Implants Market, by Application

• Chronic pain • Epilepsy • Parkinson’s disease • Depression • Essential tremor • Alzheimer’s disease

Global Brain Implants Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Global Brain Implants Market Key players

AbbottNevro Corporation • NDI Medical PLC. • Boston ScientificNeuroPace Inc. • LivaNova • Neurocontrol • St. Jude Medical • Terumo Corporation • Medtronic • Abiomed • Edwards Lifesciences Corporation • Cochlear Ltd • NeuroSigma • Functional Neuromodulation Ltd • Aleva Neurotherapeutics Sa • Synchron Inc. • Renishaw Plc
Global Brain Implants Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Brain Implants Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Brain Implants Market Analysis and Forecast 6.1. Brain Implants Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Brain Implants Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Brain Implants Market Value Share Analysis, By Product 7.4. Brain Implants Market Size (US$ Mn) Forecast, By Product 7.5. Brain Implants Market Analysis, By Product 7.6. Brain Implants Market Attractiveness Analysis, By Product 8. Global Brain Implants Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Brain Implants Market Value Share Analysis, By Application 8.4. Brain Implants Market Size (US$ Mn) Forecast, By Application 8.5. Brain Implants Market Analysis, By Application 8.6. Brain Implants Market Attractiveness Analysis, By Application 9. Global Brain Implants Market Analysis, by Region 9.1. Brain Implants Market Value Share Analysis, by Region 9.2. Brain Implants Market Size (US$ Mn) Forecast, by Region 9.3. Brain Implants Market Attractiveness Analysis, by Region 10. North America Brain Implants Market Analysis 10.1. Key Findings 10.2. North America Brain Implants Market Overview 10.3. North America Brain Implants Market Value Share Analysis, By Product 10.4. North America Brain Implants Market Forecast, By Product 10.4.1. Deep brain stimulation 10.4.2. Spinal cord stimulation 10.4.3. Vagus nerve stimulation 10.5. North America Brain Implants Market Value Share Analysis, By Application 10.6. North America Brain Implants Market Forecast, By Application 10.6.1. Chronic pain 10.6.2. Epilepsy 10.6.3. Parkinson’s disease 10.6.4. Depression 10.6.5. Essential tremor 10.6.6. Alzheimer’s disease 10.7. North America Brain Implants Market Value Share Analysis, by Country 10.8. North America Brain Implants Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Brain Implants Market Analysis, by Country 10.10. U.S. Brain Implants Market Forecast, By Product 10.10.1. Deep brain stimulation 10.10.2. Spinal cord stimulation 10.10.3. Vagus nerve stimulation 10.11. U.S. Brain Implants Market Forecast, By Application 10.11.1. Chronic pain 10.11.2. Epilepsy 10.11.3. Parkinson’s disease 10.11.4. Depression 10.11.5. Essential tremor 10.11.6. Alzheimer’s disease 10.12. Canada Brain Implants Market Forecast, By Product 10.12.1. Deep brain stimulation 10.12.2. Spinal cord stimulation 10.12.3. Vagus nerve stimulation 10.13. Canada Brain Implants Market Forecast, By Application 10.13.1. Chronic pain 10.13.2. Epilepsy 10.13.3. Parkinson’s disease 10.13.4. Depression 10.13.5. Essential tremor 10.13.6. Alzheimer’s disease 10.14. North America Brain Implants Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Brain Implants Market Analysis 11.1. Key Findings 11.2. Europe Brain Implants Market Overview 11.3. Europe Brain Implants Market Value Share Analysis, By Product 11.4. Europe Brain Implants Market Forecast, By Product 11.4.1. Deep brain stimulation 11.4.2. Spinal cord stimulation 11.4.3. Vagus nerve stimulation 11.5. Europe Brain Implants Market Value Share Analysis, By Application 11.6. Europe Brain Implants Market Forecast, By Application 11.6.1. Chronic pain 11.6.2. Epilepsy 11.6.3. Parkinson’s disease 11.6.4. Depression 11.6.5. Essential tremor 11.6.6. Alzheimer’s disease 11.7. Europe Brain Implants Market Value Share Analysis, by Country 11.8. Europe Brain Implants Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Brain Implants Market Analysis, by Country 11.10. Germany Brain Implants Market Forecast, By Product 11.10.1. Deep brain stimulation 11.10.2. Spinal cord stimulation 11.10.3. Vagus nerve stimulation 11.11. Germany Brain Implants Market Forecast, By Application 11.11.1. Chronic pain 11.11.2. Epilepsy 11.11.3. Parkinson’s disease 11.11.4. Depression 11.11.5. Essential tremor 11.11.6. Alzheimer’s disease 11.12. U.K. Brain Implants Market Forecast, By Product 11.12.1. Deep brain stimulation 11.12.2. Spinal cord stimulation 11.12.3. Vagus nerve stimulation 11.13. U.K. Brain Implants Market Forecast, By Application 11.13.1. Chronic pain 11.13.2. Epilepsy 11.13.3. Parkinson’s disease 11.13.4. Depression 11.13.5. Essential tremor 11.13.6. Alzheimer’s disease 11.14. France Brain Implants Market Forecast, By Product 11.14.1. Deep brain stimulation 11.14.2. Spinal cord stimulation 11.14.3. Vagus nerve stimulation 11.15. France Brain Implants Market Forecast, By Application 11.15.1. Chronic pain 11.15.2. Epilepsy 11.15.3. Parkinson’s disease 11.15.4. Depression 11.15.5. Essential tremor 11.15.6. Alzheimer’s disease 11.16. Italy Brain Implants Market Forecast, By Product 11.16.1. Deep brain stimulation 11.16.2. Spinal cord stimulation 11.16.3. Vagus nerve stimulation 11.17. Italy Brain Implants Market Forecast, By Application 11.17.1. Chronic pain 11.17.2. Epilepsy 11.17.3. Parkinson’s disease 11.17.4. Depression 11.17.5. Essential tremor 11.17.6. Alzheimer’s disease 11.18. Spain Brain Implants Market Forecast, By Product 11.18.1. Deep brain stimulation 11.18.2. Spinal cord stimulation 11.18.3. Vagus nerve stimulation 11.19. Spain Brain Implants Market Forecast, By Application 11.19.1. Chronic pain 11.19.2. Epilepsy 11.19.3. Parkinson’s disease 11.19.4. Depression 11.19.5. Essential tremor 11.19.6. Alzheimer’s disease 11.20. Rest of Europe Brain Implants Market Forecast, By Product 11.20.1. Deep brain stimulation 11.20.2. Spinal cord stimulation 11.20.3. Vagus nerve stimulation 11.21. Rest of Europe Brain Implants Market Forecast, By Application 11.21.1. Chronic pain 11.21.2. Epilepsy 11.21.3. Parkinson’s disease 11.21.4. Depression 11.21.5. Essential tremor 11.21.6. Alzheimer’s disease 11.22. Europe Brain Implants Market Attractiveness Analysis 11.22.1. By Product 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Brain Implants Market Analysis 12.1. Key Findings 12.2. Asia Pacific Brain Implants Market Overview 12.3. Asia Pacific Brain Implants Market Value Share Analysis, By Product 12.4. Asia Pacific Brain Implants Market Forecast, By Product 12.4.1. Deep brain stimulation 12.4.2. Spinal cord stimulation 12.4.3. Vagus nerve stimulation 12.5. Asia Pacific Brain Implants Market Value Share Analysis, By Application 12.6. Asia Pacific Brain Implants Market Forecast, By Application 12.6.1. Chronic pain 12.6.2. Epilepsy 12.6.3. Parkinson’s disease 12.6.4. Depression 12.6.5. Essential tremor 12.6.6. Alzheimer’s disease 12.7. Asia Pacific Brain Implants Market Value Share Analysis, by Country 12.8. Asia Pacific Brain Implants Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Brain Implants Market Analysis, by Country 12.10. China Brain Implants Market Forecast, By Product 12.10.1. Deep brain stimulation 12.10.2. Spinal cord stimulation 12.10.3. Vagus nerve stimulation 12.11. China Brain Implants Market Forecast, By Application 12.11.1. Chronic pain 12.11.2. Epilepsy 12.11.3. Parkinson’s disease 12.11.4. Depression 12.11.5. Essential tremor 12.11.6. Alzheimer’s disease 12.12. India Brain Implants Market Forecast, By Product 12.12.1. Deep brain stimulation 12.12.2. Spinal cord stimulation 12.12.3. Vagus nerve stimulation 12.13. India Brain Implants Market Forecast, By Application 12.13.1. Chronic pain 12.13.2. Epilepsy 12.13.3. Parkinson’s disease 12.13.4. Depression 12.13.5. Essential tremor 12.13.6. Alzheimer’s disease 12.14. Japan Brain Implants Market Forecast, By Product 12.14.1. Deep brain stimulation 12.14.2. Spinal cord stimulation 12.14.3. Vagus nerve stimulation 12.15. Japan Brain Implants Market Forecast, By Application 12.15.1. Chronic pain 12.15.2. Epilepsy 12.15.3. Parkinson’s disease 12.15.4. Depression 12.15.5. Essential tremor 12.15.6. Alzheimer’s disease 12.16. ASEAN Brain Implants Market Forecast, By Product 12.16.1. Deep brain stimulation 12.16.2. Spinal cord stimulation 12.16.3. Vagus nerve stimulation 12.17. ASEAN Brain Implants Market Forecast, By Application 12.17.1. Chronic pain 12.17.2. Epilepsy 12.17.3. Parkinson’s disease 12.17.4. Depression 12.17.5. Essential tremor 12.17.6. Alzheimer’s disease 12.18. Rest of Asia Pacific Brain Implants Market Forecast, By Product 12.18.1. Deep brain stimulation 12.18.2. Spinal cord stimulation 12.18.3. Vagus nerve stimulation 12.19. Rest of Asia Pacific Brain Implants Market Forecast, By Application 12.19.1. Chronic pain 12.19.2. Epilepsy 12.19.3. Parkinson’s disease 12.19.4. Depression 12.19.5. Essential tremor 12.19.6. Alzheimer’s disease 12.20. Asia Pacific Brain Implants Market Attractiveness Analysis 12.20.1. By Product 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Brain Implants Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Brain Implants Market Overview 13.3. Middle East & Africa Brain Implants Market Value Share Analysis, By Product 13.4. Middle East & Africa Brain Implants Market Forecast, By Product 13.4.1. Deep brain stimulation 13.4.2. Spinal cord stimulation 13.4.3. Vagus nerve stimulation 13.5. Middle East & Africa Brain Implants Market Value Share Analysis, By Application 13.6. Middle East & Africa Brain Implants Market Forecast, By Application 13.6.1. Chronic pain 13.6.2. Epilepsy 13.6.3. Parkinson’s disease 13.6.4. Depression 13.6.5. Essential tremor 13.6.6. Alzheimer’s disease 13.7. Middle East & Africa Brain Implants Market Value Share Analysis, by Country 13.8. Middle East & Africa Brain Implants Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Brain Implants Market Analysis, by Country 13.10. GCC Brain Implants Market Forecast, By Product 13.10.1. Deep brain stimulation 13.10.2. Spinal cord stimulation 13.10.3. Vagus nerve stimulation 13.11. GCC Brain Implants Market Forecast, By Application 13.11.1. Chronic pain 13.11.2. Epilepsy 13.11.3. Parkinson’s disease 13.11.4. Depression 13.11.5. Essential tremor 13.11.6. Alzheimer’s disease 13.12. South Africa Brain Implants Market Forecast, By Product 13.12.1. Deep brain stimulation 13.12.2. Spinal cord stimulation 13.12.3. Vagus nerve stimulation 13.13. South Africa Brain Implants Market Forecast, By Application 13.13.1. Chronic pain 13.13.2. Epilepsy 13.13.3. Parkinson’s disease 13.13.4. Depression 13.13.5. Essential tremor 13.13.6. Alzheimer’s disease 13.14. Rest of Middle East & Africa Brain Implants Market Forecast, By Product 13.14.1. Deep brain stimulation 13.14.2. Spinal cord stimulation 13.14.3. Vagus nerve stimulation 13.15. Rest of Middle East & Africa Brain Implants Market Forecast, By Application 13.15.1. Chronic pain 13.15.2. Epilepsy 13.15.3. Parkinson’s disease 13.15.4. Depression 13.15.5. Essential tremor 13.15.6. Alzheimer’s disease 13.16. Middle East & Africa Brain Implants Market Attractiveness Analysis 13.16.1. By Product 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Brain Implants Market Analysis 14.1. Key Findings 14.2. South America Brain Implants Market Overview 14.3. South America Brain Implants Market Value Share Analysis, By Product 14.4. South America Brain Implants Market Forecast, By Product 14.4.1. Deep brain stimulation 14.4.2. Spinal cord stimulation 14.4.3. Vagus nerve stimulation 14.5. South America Brain Implants Market Value Share Analysis, By Application 14.6. South America Brain Implants Market Forecast, By Application 14.6.1. Chronic pain 14.6.2. Epilepsy 14.6.3. Parkinson’s disease 14.6.4. Depression 14.6.5. Essential tremor 14.6.6. Alzheimer’s disease 14.7. South America Brain Implants Market Value Share Analysis, by Country 14.8. South America Brain Implants Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Brain Implants Market Analysis, by Country 14.10. Brazil Brain Implants Market Forecast, By Product 14.10.1. Deep brain stimulation 14.10.2. Spinal cord stimulation 14.10.3. Vagus nerve stimulation 14.11. Brazil Brain Implants Market Forecast, By Application 14.11.1. Chronic pain 14.11.2. Epilepsy 14.11.3. Parkinson’s disease 14.11.4. Depression 14.11.5. Essential tremor 14.11.6. Alzheimer’s disease 14.12. Mexico Brain Implants Market Forecast, By Product 14.12.1. Deep brain stimulation 14.12.2. Spinal cord stimulation 14.12.3. Vagus nerve stimulation 14.13. Mexico Brain Implants Market Forecast, By Application 14.13.1. Chronic pain 14.13.2. Epilepsy 14.13.3. Parkinson’s disease 14.13.4. Depression 14.13.5. Essential tremor 14.13.6. Alzheimer’s disease 14.14. Rest of South America Brain Implants Market Forecast, By Product 14.14.1. Deep brain stimulation 14.14.2. Spinal cord stimulation 14.14.3. Vagus nerve stimulation 14.15. Rest of South America Brain Implants Market Forecast, By Application 14.15.1. Chronic pain 14.15.2. Epilepsy 14.15.3. Parkinson’s disease 14.15.4. Depression 14.15.5. Essential tremor 14.15.6. Alzheimer’s disease 14.16. South America Brain Implants Market Attractiveness Analysis 14.16.1. By Product 14.16.2. By Application 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.4. M&A by Regions, Investment and Applications 15.2.5. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Abbott 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Nevro Corporation 15.3.3. NDI Medical PLC. 15.3.4. Boston Scientific 15.3.5. NeuroPace Inc. 15.3.6. LivaNova 15.3.7. Neurocontrol 15.3.8. St. Jude Medical 15.3.9. Terumo Corporation 15.3.10. Medtronic 15.3.11. Abiomed 15.3.12. Edwards Lifesciences Corporation 15.3.13. Cochlear Ltd 15.3.14. NeuroSigma 15.3.15. Functional Neuromodulation Ltd 15.3.16. Aleva Neurotherapeutics Sa 15.3.17. Synchron Inc. 15.3.18. Renishaw Plc

About This Report

Report ID 66951
Category Healthcare
Published Date July 2020
Updated Date June 2021
Contact Us